-
公开(公告)号:EP1761553B1
公开(公告)日:2009-10-21
申请号:EP05752606.3
申请日:2005-05-24
发明人: WEINSCHENK, Toni , LEMMEL, Claudia , RAMMENSEE, Hans-Georg , STEVANOVIC, Stefan, Institut für Zellbiologie
CPC分类号: C07K14/4748
摘要: The invention relates to a tumor-associated peptide with an amino acid sequence that is selected from the group consisting of SEQ ID-Nr. 1 to SEQ ID-Nr. 577 from the annexed sequence protocol. The peptide is capable of binding to a molecule of the human main histocompatibility complex (MHC) class I. The invention also relates to the use of peptides for producing a medicament and for treating tumor diseases and/or adenomatous diseases. The invention also relates to a pharmaceutical composition containing at least one of the peptides.
-
公开(公告)号:EP1761553A2
公开(公告)日:2007-03-14
申请号:EP05752606.3
申请日:2005-05-24
发明人: WEINSCHENK, Toni , LEMMEL, Claudia , RAMMENSEE, Hans-Goerg , STEVANOVIC, Stefan, Institut für Zellbiologie
CPC分类号: C07K14/4748
摘要: The invention relates to a tumor-associated peptide with an amino acid sequence that is selected from the group consisting of SEQ ID-Nr. 1 to SEQ ID-Nr. 577 from the annexed sequence protocol. The peptide is capable of binding to a molecule of the human main histocompatibility complex (MHC) class I. The invention also relates to the use of peptides for producing a medicament and for treating tumor diseases and/or adenomatous diseases. The invention also relates to a pharmaceutical composition containing at least one of the peptides.
-